Home  >  Feik School of Pharmacy  >  About Us  >    >  Marcos Oliveira, Ph.D.

Marcos Oliveira, Ph.D.

PHONE: (210) 883-1089

Dr. Marcos OliveiraDr. Marcos A. Oliveira is originally from Brazil where he received his undergraduate in Physics and Masters in Applied Physics. He then moved to the US to Purdue University where he received his Ph.D. in Structural Biology, his work at Purdue contributed to the development of a novel antiviral agent pleconaril. He did a post-doctoral training at the Protein Crystallography group at UT-Austin.  He then began his career in Pharmacy as a faculty member at the University of Kentucky, College of Pharmacy. In 2006 he joined the team of Dr. Arcelia Johnson-Fannin and helped establish a new School of Pharmacy at the University of the Incarnate Word.  He is an author of over forty scientific manuscripts in peer reviewed journals. He has received funding from the American Cancer Society, Kentucky Lung Cancer Research Program, William and Ella Owens Biomedical Research foundation and NIH. He is currently working on the development of novel antibacterial agents in collaboration with biotech companies in San Antonio. In 2009 he was selected by Aetna along with a group of 12 health professionals as examples of Latino contemporary role models and in 2010 was selected for the Academic Leadership Fellows Program of the American Association of Colleges of Pharmacy (AACP). The leadership experience provided by AACP and UIW has provided him the tools to initiate an innovative global Pharmacy exchange program involving two private organizations in Brazil (Pharmaceutical company Prati-Donaduzzi, an academic partner in the area of Pharmacy education, PUC-Parana and an American Pharmacy chain H-E-B). The exchange program has provided Brazilian Pharmacy students to learn about Clinical Pharmacy in the US and for UIW Pharmacy students to gain a unique experience in Industrial Pharmacy developing a comparative understanding of FDA and the Brazilian counterpart ANVISA.

Research projects focus on:  Education: Developing novel educational methods that focus on using technology to enhance students engagement.  Drug Discovery: Our overall goal is the investigation of a novel mechanism of biofilm regulation involving polyamines and the identification of novel targets for drug discovery. In collaboration with Dr. Robert Perry and Jackeline Fetherston we are investigating the function of polyamines in Yersinia pestis (Plague) to develop novel biodefense agents. In collaboration with Dr. Patrick Woster we are working to identify small molecular weight compounds that interfere with polyamine metabolism in bacteria  In collaboration with Dr. Mary Pat Moyer at INCELL we are translating our discoveries into novel therapeutics.

Linked in Button